Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Wockhardt

Clinicaltrial registered21 Oct 2026

Wockhardt

21 Oct 2026: Trial registered · Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
21 Oct 2026
Title
Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia
Conditions
Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP)
Phase
Phase 3
Study Type
Interventional
Status
Not Yet Recruiting
Countries
Bosnia and Herzegovina, Bulgaria, Croatia, France, Georgia, Greece, India, Italy, Lithuania, Moldova, North Macedonia, Poland, Romania, Serbia
Country
Bosnia and Herzegovina
Reference
NCT07885891
Location
Bosnia and Herzegovina, Bulgaria, Croatia
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Wockhardt

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.